Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mila Donker

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
International Journal of Radiation Oncology, Biology, Physics|January 19, 2020
MRI-Based Upper Abdominal Organs-at-Risk Atlas for Radiation OncologyJelena Lukovic, Lauren Henke, Cihan Gani, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2013
Comparison of the sentinel node procedure between patients with multifocal and unifocal breast cancer in the EORTC 10981-22023 AMAROS Trial: identification rate and nodal outcomeMila Donker, Marieke E Straver, Geertjan van Tienhoven, et al.
European Urology|August 6, 2022
Phase 1 Study of Chemoradiotherapy Combined with Nivolumab ± Ipilimumab for the Curative Treatment of Muscle-invasive Bladder CancerBen-Max de Ruiter, Jons W van Hattum, Djoeri Lipman, et al.
Clinical and Translational Radiation Oncology|February 12, 2026
Dynamic immune changes after bone marrow sparing VMAT in women with locally advanced cervical cancer treated with chemoradiotherapyAnouk Corbeau, Marij J P Welters, Sanne Boekestijn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2022
Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS TrialSanne A L Bartels, Mila Donker, Coralie Poncet, et al.
The Lancet. Oncology|December 3, 2014
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trialMila Donker, Geertjan van Tienhoven, Marieke E Straver, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
International Journal of Radiation Oncology, Biology, Physics|January 19, 2020
MRI-Based Upper Abdominal Organs-at-Risk Atlas for Radiation OncologyJelena Lukovic, Lauren Henke, Cihan Gani, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2013
Comparison of the sentinel node procedure between patients with multifocal and unifocal breast cancer in the EORTC 10981-22023 AMAROS Trial: identification rate and nodal outcomeMila Donker, Marieke E Straver, Geertjan van Tienhoven, et al.
European Urology|August 6, 2022
Phase 1 Study of Chemoradiotherapy Combined with Nivolumab ± Ipilimumab for the Curative Treatment of Muscle-invasive Bladder CancerBen-Max de Ruiter, Jons W van Hattum, Djoeri Lipman, et al.
Clinical and Translational Radiation Oncology|February 12, 2026
Dynamic immune changes after bone marrow sparing VMAT in women with locally advanced cervical cancer treated with chemoradiotherapyAnouk Corbeau, Marij J P Welters, Sanne Boekestijn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2022
Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS TrialSanne A L Bartels, Mila Donker, Coralie Poncet, et al.
The Lancet. Oncology|December 3, 2014
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trialMila Donker, Geertjan van Tienhoven, Marieke E Straver, et al.
Pageof 2